Anika Therapeutics, Inc. (ANIK) Operating margin 2016–2025
Anika Therapeutics, Inc. (ANIK) operating margin by fiscal year — reported operating income divided by reported revenue.
-9.8%FY2025 · since FY2016: 49.0% → -9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.8% | -5.5 pp |
| FY2024 | -4.3% | -5.0 pp |
| FY2023 | 0.7% | -2.5 pp |
| FY2022 | 3.2% | +1.5 pp |
| FY2021 | 1.8% | +23.5 pp |
| FY2020 | -21.7% | -51.6 pp |
| FY2019 | 29.9% | +9.3 pp |
| FY2018 | 20.6% | -19.7 pp |
| FY2017 | 40.3% | -8.6 pp |
| FY2016 | 49.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice